EMT has recently been linked to basal-like breast cancer as demonstrated by upregulation of EMT markers (Vimentin, alpha-smooth muscle actin, and N-Cad) together with reduction of characteristic epithelial markers (E-Cad and keratins) [9], [11]. This evidence concerns the gene CDH2 and breast carcinoma.